Colchicine, a gout drug, shows preliminary promise for Covid-19 – STAT
Mashup Score: 429
STAT - Colchicine, a drug commonly used to treat gout, could reduce the risk people with mild Covid-19 will need to be
Source:
NPR.org
New clues on COVID-19 long-haulers from Italy, an early hot spot
posted 18 hours
Source:
American Medical Association
Why we need to rethink COVID-19 risk as the weather warms up
posted 21 hours
Source:
www.cbc.ca
The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine - PubMed
posted 22 hours
Source:
PubMed
Grandparents and vaccines: Now what? - Harvard Health Blog
posted 16 hours
Source:
Harvard Health Blog
Dexamethasone and Covid-19 | NEJM
posted 17 hours
Source:
New England Journal of Medicine
FDA Wants Anti-COVID-19 Variant Boosters Out Quickly
posted 18 hours
Source:
Infection Control Today
Source:
Los Angeles Times
Source:
CNN
The Podcast by KevinMD: Is there a role for vitamin D in COVID-19? on Apple Podcasts
posted 20 hours
Source:
Apple Podcasts
How to Dispel Myths About the COVID-19 Vaccine
posted 17 hours
Source:
Consult QD
MMR Vaccine Shows Some COVID-19 Protection
posted 19 hours
Source:
HCPLive
Source:
Flipboard
Source: U.S.
Source: Financial Times
Source: U.S.
Source: U.S.
SARS-CoV-2 antibodies and risk of future infection
posted 2 hours
Source: National Cancer Institute
Great article from @statnews with opinions from top researchers who are hopeful but are concerned about cherry picked results. h/t @AustinIsabel A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release https://t.co/iSG8FDPbvw